New Mountain Vantage Advisers Decreased Its Aetna New (AET) Holding; Ocera Therapeutics (OCRX) Has 0.4 Sentiment

January 14, 2018 - By Michael Collier

Ocera Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The company has market cap of $47.46 million. It focuses on the development and commercialization of OCR-002, which is in Phase IIb trials for the treatment of hyperammonemia and hepatic encephalopathy in patients with liver cirrhosis, acute liver injury or failure, and in the areas of unmet medical need. It currently has negative earnings.

New Mountain Vantage Advisers Llc decreased Aetna Inc New (AET) stake by 7.8% reported in 2017Q3 SEC filing. New Mountain Vantage Advisers Llc sold 22,266 shares as Aetna Inc New (AET)’s stock rose 12.84%. The New Mountain Vantage Advisers Llc holds 263,283 shares with $41.87M value, down from 285,549 last quarter. Aetna Inc New now has $60.08 billion valuation. The stock decreased 0.01% or $0.01 during the last trading session, reaching $184.2. About 2.41M shares traded. Aetna Inc. (NYSE:AET) has risen 28.84% since January 14, 2017 and is uptrending. It has outperformed by 12.14% the S&P500.

Among 24 analysts covering Aetna (NYSE:AET), 10 have Buy rating, 0 Sell and 14 Hold. Therefore 42% are positive. Aetna had 64 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was maintained by Cowen & Co on Friday, May 26 with “Buy”. The company was maintained on Wednesday, November 1 by Jefferies. The firm has “Hold” rating by Jefferies given on Wednesday, June 7. As per Tuesday, May 16, the company rating was maintained by Stifel Nicolaus. The stock has “Hold” rating by Deutsche Bank on Thursday, July 13. PiperJaffray upgraded the stock to “Overweight” rating in Wednesday, January 3 report. The firm earned “Hold” rating on Tuesday, October 31 by Cantor Fitzgerald. The stock of Aetna Inc. (NYSE:AET) earned “Mkt Perform” rating by Bernstein on Monday, November 14. The firm has “Overweight” rating given on Wednesday, June 7 by Morgan Stanley. The firm has “Buy” rating given on Monday, December 4 by RBC Capital Markets.

Analysts await Aetna Inc. (NYSE:AET) to report earnings on January, 30. They expect $1.18 EPS, down 27.61% or $0.45 from last year’s $1.63 per share. AET’s profit will be $384.88 million for 39.03 P/E if the $1.18 EPS becomes a reality. After $2.45 actual EPS reported by Aetna Inc. for the previous quarter, Wall Street now forecasts -51.84% negative EPS growth.

New Mountain Vantage Advisers Llc increased Bellerophon Therapeutics Inc stake by 4.56 million shares to 15.14M valued at $20.08 million in 2017Q3. It also upped Alphabet Inc stake by 18,293 shares and now owns 35,188 shares. Allergan Plc was raised too.

Since September 15, 2017, it had 0 insider purchases, and 2 selling transactions for $4.15 million activity. McCarthy Margaret M sold 10,288 shares worth $1.68M. Another trade for 15,271 shares valued at $2.47M was made by Lynch Karen S on Monday, September 18.

Investors sentiment increased to 0.91 in 2017 Q3. Its up 0.22, from 0.69 in 2017Q2. It increased, as 42 investors sold AET shares while 302 reduced holdings. 80 funds opened positions while 232 raised stakes. 281.08 million shares or 3.09% less from 290.06 million shares in 2017Q2 were reported. Cambridge Grp Incorporated reported 3.6% stake. Franklin holds 0.08% or 1.07M shares. Comerica State Bank holds 108,354 shares or 0.13% of its portfolio. Hanson Doremus Invest holds 38 shares or 0% of its portfolio. Hbk Investments Lp reported 11,400 shares. Sabal Trust Co owns 12,000 shares. Segment Wealth Mgmt Ltd Liability Corporation holds 0.09% or 2,069 shares. Davis Selected Advisers stated it has 3.82 million shares. Wendell David Associate stated it has 2,000 shares or 0.06% of all its holdings. Dynamic Advsrs Solutions Ltd Liability invested in 0.15% or 2,406 shares. Wetherby Asset Mngmt has invested 0.16% of its portfolio in Aetna Inc. (NYSE:AET). Proshare Limited Co has 0.06% invested in Aetna Inc. (NYSE:AET) for 37,739 shares. California State Teachers Retirement System holds 0.2% or 569,673 shares in its portfolio. Calamos Advsr Ltd Company reported 376,748 shares. Commonwealth Of Pennsylvania Pub School Empls Retrmt invested in 0.06% or 26,976 shares.

Ratings analysis reveals 67% of Ocera Therapeutics’s analysts are positive. Out of 3 Wall Street analysts rating Ocera Therapeutics, 2 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. OCRX was included in 3 notes of analysts from November 4, 2016. The stock of Ocera Therapeutics, Inc. (NASDAQ:OCRX) earned “Buy” rating by Aegis Capital on Friday, November 4. The stock of Ocera Therapeutics, Inc. (NASDAQ:OCRX) earned “Buy” rating by H.C. Wainwright on Wednesday, December 28. JMP Securities downgraded the shares of OCRX in report on Tuesday, January 31 to “Mkt Perform” rating.

Hikari Power Ltd holds 0.1% of its portfolio in Ocera Therapeutics, Inc. for 676,596 shares. Perceptive Advisors Llc owns 2.04 million shares or 0.09% of their US portfolio. Moreover, Knott David M has 0.02% invested in the company for 39,800 shares. The New York-based A.R.T. Advisors Llc has invested 0% in the stock. Bank Of New York Mellon Corp, a New York-based fund reported 31,880 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts